October 27, 2022 12:54 PM EDT
R&D
Manufacturing

Man­u­fac­tur­ing roundup: Symeres buys CRO in New Jer­sey; Cam­brex in­vests $16M+ in Min­neso­ta and Iowa fa­cil­i­ties

Tyler Patchen

News Reporter

Dutch CD­MO Symeres has ac­quired a com­pa­ny to fur­ther strength­en its po­si­tion in the US.

The com­pa­ny is buy­ing Ex­em­pli­fy Bio­Phar­ma, a CRO that pro­vides …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

The elec­tion is Tues­day. What’s at stake for the phar­ma in­dus­try?

'We play to win': As­traZeneca de­tails first re­sults for oral GLP-1 and broad­er obe­si­ty am­bi­tions

Is there room for MASH drugs in a GLP-1 world?

Viking's oral weight loss drug ap­pears to have strong ef­fect in Phase 1 tri­al

Rare dis­ease bio­phar­ma com­pa­nies weigh in on FDA's new in­no­va­tion hub

sponsored

Gene ther­a­pies don’t have to cost $4 mil­lion: New pro­duc­tion plat­forms re­duce de­vel­op­ment costs and risks

A service from the Financial Times